MDAI vs BVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

MDAI

44.8
AI Score
VS
MDAI Wins

BVS

41.2
AI Score

Investment Advisor Scores

MDAI

45score
Recommendation
HOLD

BVS

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDAI BVS Winner
Revenue 7.51M 285.30M BVS
Net Income -7.59M 36.55M BVS
Gross Margin 41.8% 68.9% BVS
Net Margin -101.0% 12.8% BVS
Operating Income -6.29M 27.54M BVS
ROE 63.0% 16.0% MDAI
ROA -39.0% 5.4% BVS
Total Assets 19.44M 673.35M BVS
Cash 14.00M 29.46M BVS
Debt/Equity -0.92 1.01 MDAI
Current Ratio 0.90 1.69 BVS

Relative Price Performance (Last 90 Days)

MDAI 1M: -9.6% · 3M: -8.5% BVS 1M: +10.5% · 3M: +27.5%

Current Technical Phase

MDAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 35

RSI (14): 35.4 · Price: $1.50

BVS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 67

RSI (14): 67.1 · Price: $15.04

Fundamentals Snapshot

Metric MDAI BVS
Market Cap — —
Forward P/E -4.8 16.4
Trailing P/E — 18.3
Revenue (TTM) — —
Revenue Growth -0.3% 0.0%
Gross Margin 0.4% 0.7%
Operating Margin -1.2% 0.1%
EPS -0.32 0.78
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MDAI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.